A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length

Huntington's disease (HD) is a neurodegenerative disorder caused by an unstable CAG repeat. For patients at risk, participating in predictive testing and learning of having CAG expansion, a major unanswered question shifts from “Will I get HD?” to “When will it manifest?” Using the largest cohort of HD patients analyzed to date (2913 individuals from 40 centers worldwide), we developed a parametric survival model based on CAG repeat length to predict the probability of neurological disease onset (based on motor neurological symptoms rather than psychiatric onset) at different ages for individual patients. We provide estimated probabilities of onset associated with CAG repeats between 36 and 56 for individuals of any age with narrow confidence intervals. For example, our model predicts a 91% chance that a 40‐year‐old individual with 42 repeats will have onset by the age of 65, with a 95% confidence interval from 90 to 93%. This model also defines the variability in HD onset that is not attributable to CAG length and provides information concerning CAG‐related penetrance rates.

[1]  Jane S. Paulsen,et al.  A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. , 2003, American journal of human genetics.

[2]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[3]  M. MacDonald,et al.  Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease , 2003, American journal of medical genetics. Part A.

[4]  B. Fernandez,et al.  Predictive, pre‐natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000 , 2003, Clinical genetics.

[5]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .

[6]  G. van Ommen,et al.  Predictability of Age at Onset in Huntington Disease in the Dutch Population , 2002, Medicine.

[7]  D. Falush,et al.  Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. , 2001, American journal of human genetics.

[8]  B. Meiser,et al.  Psychological impact of genetic testing for Huntington's disease: an update of the literature , 2000, Journal of neurology, neurosurgery, and psychiatry.

[9]  M. MacDonald,et al.  Evidence for the GluR6 gene associated with younger onset age of Huntington’s disease , 1999, Neurology.

[10]  D. Avramopoulos,et al.  Apolipoprotein E and presenilin-1 genotypes in Huntington’s disease , 1999, Journal of Neurology.

[11]  M. Hayden,et al.  Accurate determination of the number of CAG repeats in the Huntington disease gene using a sequence‐specific internal DNA standard , 1999, Clinical genetics.

[12]  M. Owen,et al.  Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length , 1999, Journal of medical genetics.

[13]  M. Wick,et al.  Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington’s disease , 1999, Neurology.

[14]  A. Destée,et al.  Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.

[15]  M. Hayden,et al.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. , 1997, American journal of human genetics.

[16]  M. MacDonald,et al.  Reduced penetrance of the Huntington's disease mutation. , 1997, Human molecular genetics.

[17]  G Norbury,et al.  Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P S Harper,et al.  Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. , 1996, American journal of human genetics.

[19]  J. Brandt,et al.  Trinucleotide repeat length and clinical progression in Huntington's disease , 1996, Neurology.

[20]  S. Folstein,et al.  Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. , 1995, American journal of human genetics.

[21]  S. Hazout,et al.  Confidence intervals for predicted age of onset, given the size of (CAG)n repeat, in Huntington's disease , 1995, Human Genetics.

[22]  Paul W Goldberg,et al.  A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. , 1994, The New England journal of medicine.

[23]  J. Mandel,et al.  Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. , 1994, Journal of medical genetics.

[24]  C A Ross,et al.  Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. , 1993, Human molecular genetics.

[25]  M. Hayden,et al.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.

[26]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[27]  M. MacDonald,et al.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease , 1993, Nature Genetics.

[28]  D. Brock,et al.  A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. , 1993, Molecular and cellular probes.

[29]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[30]  D. Craufurd,et al.  Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium. , 1992, BMJ.

[31]  Joseph B. Martin Huntington's disease , 1984, Neurology.

[32]  G. Reinsel,et al.  Introduction to Mathematical Statistics (4th ed.). , 1980 .

[33]  F. Downton,et al.  Introduction to Mathematical Statistics , 1959 .

[34]  C Worster-Drought,et al.  HUNTINGTON'S CHOREA , 1929, British medical journal.

[35]  Mary Ann Branch,et al.  Optimization Toolbox User's Guide , 1998 .

[36]  Stephen Wolfram,et al.  The Mathematica Book , 1996 .

[37]  R. F.,et al.  Mathematical Statistics , 1944, Nature.